 James Morrison
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lentiviruses, Primate | 3 | 2023 | 13 | 1.640 |
Why?
| | Immunodeficiency Virus, Feline | 2 | 2023 | 30 | 1.290 |
Why?
| | Immunity, Innate | 5 | 2020 | 731 | 0.740 |
Why?
| | Spumavirus | 1 | 2020 | 2 | 0.740 |
Why?
| | Gammaretrovirus | 1 | 2020 | 2 | 0.740 |
Why?
| | Chiroptera | 1 | 2020 | 50 | 0.690 |
Why?
| | HIV-1 | 8 | 2021 | 771 | 0.680 |
Why?
| | Cats | 3 | 2023 | 204 | 0.500 |
Why?
| | Virion | 2 | 2019 | 74 | 0.480 |
Why?
| | Lentivirus Infections | 1 | 2014 | 7 | 0.460 |
Why?
| | Cat Diseases | 1 | 2014 | 14 | 0.460 |
Why?
| | Viral Envelope Proteins | 1 | 2014 | 74 | 0.440 |
Why?
| | Virus Replication | 6 | 2021 | 396 | 0.430 |
Why?
| | Picornaviridae | 3 | 2020 | 18 | 0.380 |
Why?
| | Antigens, CD | 1 | 2014 | 442 | 0.380 |
Why?
| | Interferons | 2 | 2022 | 152 | 0.360 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 2 | 2020 | 14 | 0.350 |
Why?
| | Amino Acid Sequence | 3 | 2023 | 2000 | 0.260 |
Why?
| | Capsid | 2 | 2021 | 76 | 0.220 |
Why?
| | Bone Marrow Stromal Antigen 2 | 1 | 2023 | 2 | 0.220 |
Why?
| | Human Immunodeficiency Virus Proteins | 1 | 2023 | 6 | 0.220 |
Why?
| | Protein Sorting Signals | 1 | 2023 | 16 | 0.220 |
Why?
| | HIV Integrase | 3 | 2014 | 67 | 0.220 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2023 | 27 | 0.220 |
Why?
| | GPI-Linked Proteins | 1 | 2023 | 54 | 0.220 |
Why?
| | Virus Integration | 3 | 2021 | 68 | 0.210 |
Why?
| | Reverse Transcription | 2 | 2021 | 19 | 0.210 |
Why?
| | Saliva | 1 | 2023 | 189 | 0.200 |
Why?
| | RNA Interference | 3 | 2020 | 438 | 0.200 |
Why?
| | HEK293 Cells | 2 | 2020 | 602 | 0.190 |
Why?
| | Aotidae | 1 | 2020 | 7 | 0.180 |
Why?
| | Ferrets | 1 | 2020 | 20 | 0.180 |
Why?
| | Tripartite Motif Proteins | 1 | 2020 | 29 | 0.180 |
Why?
| | Host-Pathogen Interactions | 4 | 2021 | 296 | 0.180 |
Why?
| | Cyclophilin A | 1 | 2020 | 24 | 0.180 |
Why?
| | 3T3 Cells | 1 | 2020 | 137 | 0.180 |
Why?
| | Cell Line | 4 | 2020 | 2651 | 0.180 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 83 | 0.180 |
Why?
| | RNA Virus Infections | 1 | 2019 | 11 | 0.170 |
Why?
| | RNA, Viral | 2 | 2020 | 565 | 0.170 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 44 | 0.170 |
Why?
| | Animals | 10 | 2023 | 32102 | 0.170 |
Why?
| | RNA Viruses | 1 | 2019 | 28 | 0.170 |
Why?
| | Amino Acids | 1 | 2023 | 454 | 0.170 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2020 | 31 | 0.160 |
Why?
| | Exodeoxyribonucleases | 1 | 2018 | 24 | 0.160 |
Why?
| | Nucleotidyltransferases | 1 | 2018 | 26 | 0.160 |
Why?
| | RNA, Small Interfering | 1 | 2020 | 544 | 0.150 |
Why?
| | Antiviral Agents | 2 | 2022 | 651 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2011 | 374 | 0.140 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 443 | 0.140 |
Why?
| | DNA, Viral | 1 | 2018 | 351 | 0.140 |
Why?
| | Phosphoproteins | 1 | 2018 | 304 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2023 | 2574 | 0.130 |
Why?
| | Genes, Viral | 1 | 2015 | 89 | 0.130 |
Why?
| | Mice | 7 | 2020 | 15052 | 0.130 |
Why?
| | Anti-HIV Agents | 1 | 2020 | 669 | 0.120 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 99 | 0.120 |
Why?
| | Viral Proteins | 1 | 2015 | 286 | 0.110 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2790 | 0.110 |
Why?
| | Sequence Alignment | 1 | 2014 | 327 | 0.110 |
Why?
| | Dogs | 1 | 2014 | 341 | 0.110 |
Why?
| | Molecular Chaperones | 1 | 2014 | 157 | 0.110 |
Why?
| | Transcription Factors | 2 | 2011 | 1528 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2014 | 362 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2014 | 965 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 535 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 616 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2020 | 1970 | 0.080 |
Why?
| | Chromatin | 2 | 2009 | 429 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2021 | 111 | 0.070 |
Why?
| | HIV Infections | 2 | 2014 | 2473 | 0.070 |
Why?
| | Humans | 14 | 2023 | 115587 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 350 | 0.070 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 94 | 0.050 |
Why?
| | Nuclear Pore | 1 | 2021 | 14 | 0.050 |
Why?
| | Acute Disease | 1 | 2023 | 914 | 0.050 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 29 | 0.050 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2020 | 26 | 0.050 |
Why?
| | Protein Binding | 2 | 2021 | 1917 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2021 | 198 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 222 | 0.040 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2020 | 6 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 22 | 0.040 |
Why?
| | Cytoplasm | 1 | 2021 | 255 | 0.040 |
Why?
| | Disease Resistance | 1 | 2020 | 28 | 0.040 |
Why?
| | Immune Evasion | 1 | 2020 | 47 | 0.040 |
Why?
| | Retroviridae Infections | 1 | 2020 | 45 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2020 | 144 | 0.040 |
Why?
| | Interferon-beta | 1 | 2020 | 79 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 511 | 0.040 |
Why?
| | Vero Cells | 1 | 2019 | 65 | 0.040 |
Why?
| | Protein Domains | 1 | 2020 | 209 | 0.040 |
Why?
| | Viremia | 1 | 2020 | 122 | 0.040 |
Why?
| | Embryonic Development | 1 | 2020 | 115 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 408 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 129 | 0.040 |
Why?
| | HeLa Cells | 1 | 2020 | 567 | 0.040 |
Why?
| | Genome, Viral | 1 | 2019 | 121 | 0.040 |
Why?
| | THP-1 Cells | 1 | 2018 | 20 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4773 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2015 | 2604 | 0.040 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 377 | 0.040 |
Why?
| | Viral Load | 1 | 2020 | 405 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2021 | 553 | 0.040 |
Why?
| | Binding Sites | 1 | 2021 | 1177 | 0.040 |
Why?
| | Monocytes | 1 | 2018 | 507 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2015 | 298 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 794 | 0.030 |
Why?
| | Cyclophilins | 1 | 2014 | 29 | 0.030 |
Why?
| | Virus Assembly | 1 | 2014 | 67 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 746 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 930 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 795 | 0.030 |
Why?
| | Virus Diseases | 1 | 2015 | 200 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 281 | 0.030 |
Why?
| | Biomarkers | 1 | 2023 | 3466 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1153 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2011 | 3914 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1642 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1000 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2011 | 257 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2009 | 136 | 0.020 |
Why?
| | Antigens, Viral | 1 | 2009 | 177 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 4541 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 804 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1024 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2114 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2009 | 675 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2009 | 594 | 0.020 |
Why?
| | Histones | 1 | 2009 | 540 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2009 | 1310 | 0.010 |
Why?
| | Male | 2 | 2020 | 55949 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1316 | 0.010 |
Why?
| | Female | 2 | 2020 | 59913 | 0.010 |
Why?
|
|
Morrison's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|